The power of R&D collaborations to improve outcomes in rare diseases
pharmaphorum
OCTOBER 7, 2021
However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. His academic and clinical focus is on benign haematology, where he has a particular interest in sickle cell disease, haemophilia and other rare blood disorders.
Let's personalize your content